Plasma and synovial fluid endothelin-1 and nitric oxide concentrations in horses with and without joint disease

American Journal of Veterinary Research

Volumn 63, Issue 12, 2002, Pages 1648-1654

  de la Calle, Jorge ^a   Burba, Daniel J ^a   Ramaswamy, Chidambaram M ^d   Hosgood, Giselle ^a   Williams, Jamil ^a   LeBlanc, Casey ^b   Moore, Rustin M ^b,c,d  

^a San Agustin de Guadalix   (Spain)

^b Department of Veterinary Clin Sci ^*  (United States)

^c Pathobiological Sciences   (United States)

^d LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE;

ARTHROCENTESIS; ARTHROPATHY; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HORSE; INFECTIOUS ARTHRITIS; JOINT RADIOGRAPHY; JUGULAR VEIN; MALE; NONHUMAN; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; SAPHENOUS VEIN; SYNOVIAL FLUID LEVEL; SYNOVITIS;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0036911907     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2002.63.1648     Document Type: Article

References (54)

1. Jeffcot LB, Rossdale PD, Freestone J, et al. An assessment of wastage in Thoroughbred racing from conception to 4 years of age. Equine Vet J 1982;14:185-198.
2. Rossdale PD, Hopes R, Wingfield-Digby NJ, et al. Epidemiological study of wastage among racehorses, 1982 and 1983. Vet Rec 1985;116:66-70.
3. McIlwraith CW. General pathobiology of the joint and response to injury. In: McIlwraith CW, Trotter GW, eds. Joint disease in the horse. Philadelphia: WB Saunders Co, 1996;40-70.
4. Farrell AJ, Blake DR, Palmer RM, et al. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-1222.
5. Grabowski PS, England AJ, Dykhuizen R, et al. Elevated nitric oxide production in rheumatoid arthritis. Detection using the fasting urinary nitrate: creatinine ratio. Arthritis Rheum 1996;39:643-647.
6. Hilliquin P, Borderie D, Hernvann A, et al. Nitric oxide as S-nitrosoproteins in rheumatoid arthritis. Arthritis Rheum 1997;40:1512-1517.
7. Sakurai H, Kohsaka H, Liu MF, et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995;96:2357-2363.
8. Ueki Y, Miyake S, Tominaga Y, et al. Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 1996;23:230-236.
9. Miyasaka N, Hirata Y, Ando K, et al. Increased production of endothelin-1 in patients with inflammatory arthritides. Arthritis Rheum 1992;35:397-400.
10. Haq A, El-Ramahi K, Al-Dalaan A, et al. Serum and synovial fluid concentrations of endothelin-1 in patients with rheumatoid arthritis. J Med 1999;30:51-60.
11. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-142.
12. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
13. Ignarro LJ, Buga GM, Wood KS, et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987;84:9265-9269.
14. Hare JM, Keaney JF Jr, Balligand JL, et al. Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs. J Clin Invest 1995;95:360-366.
15. Dugas B, Debre P, Moncada S. Nitric oxide, a vital poison inside the immune and inflammatory network. Res Immunol 1995; 146:664-670.
16. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26:48-57.
17. Kubes P. Nitric oxide affects microvascular permeability in the intact and inflamed vasculature. Microcirculation 1995;2:235-244.
18. Spreng D, Sigrist N, Schweighauser A, et al. Endogenous nitric oxide production in canine osteoarthritis: detection in urine, serum, and synovial fluid specimens. Vet Surg 2001;30:191-199.
19. Hauselmann HJ, Oppliger L, Michel BA, et al. Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture. FEBS Lett 1994;352:361-364.
20. Stadler J, Stefanovic-Racic M, Billiar TR, et al. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 1991;147:3915-3920.
21. von Rechenberg B, McIlwraith CW, Akens MK, et al. Spontaneous production of nitric oxide (NO), prostaglandin (PGE2) and neutral metalloproteinases (NMPs) in media of explant cultures of equine synovial membrane and articular cartilage from normal and osteoarthritic joints. Equine Vet J 2000;32:140-150.
22. von Rechenberg B, Guenther H, McIlwraith CW, et al. Fibrous tissue of subchondral cystic lesions in horses produce local mediators and neutral metalloproteinases and cause bone resorption in vitro. Vet Surg 2000;29:420-429.
23. Murrell GA, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995;206:15-21.
24. Evans CH, Stefanovic-Racic M, Lancaster J. Nitric oxide and its role in orthopaedic disease. Clin Orthop 1995:275-294.
25. Taskiran D, Stefanovic-Racic M, Georgescu H, et al. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun 1994;200:142-148.
26. Pelletier JP, Mineau F, Ranger P, et al. The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 1996;4:77-84.
27. Lotz M, Hashimoto S, Kuhn K. Mechanisms of chondrocyte apoptosis. Osteoarthritis Cartilage 1999;7:389-391.
28. Salvemini D, Manning PT, Zweifel BS, et al. Dual inhibition of nitric oxide and prostaglandin production contributes to the anti-inflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 1995;96:301-308.
29. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
30. Suzuki N, Matsumoto H, Kitada C, et al. Production of endothelin-1 and big-endothelin-1 by tumor cells with epithelial-like morphology. J Biochem (Tokyo) 1989;106:736-741.
31. Sakamoto H, Sasaki S, Hirata Y, et al. Production of endothelin-1 by rat cultured mesangial cells. Biochem Biophys Res Commun 1990;169:462-468.
32. Ohta K, Hirata Y, Imai T, et al. Cytokine-induced release of endothelin-1 from porcine renal epithelial cell line. Biochem Biophys Res Commun 1990;169:578-584.
33. Khatib AM, Lomri A, Moldovan F, et al. Constitutive and inducible expression of endothelin-1 in primary rat articular chondrocyte culture. Cytokine 1997;9:556-562.
34. Yoshida H, Imafuku Y, Ohhara M, et al. Endothelin-1 production by human synoviocytes. Ann Clin Biochem 1998;35:290-294.
35. Wharton J, Rutherford RA, Walsh DA, et al. Autoradiographic localization and analysis of endothelin-1 binding sites in human synovial tissue. Arthritis Rheum 1992;35:894-899.
36. Stojilkovic SS, Vukicevic S, Luyten FP. Calcium signaling in endothelin- and platelet-derived growth factor-stimulated chondrocytes. J Bone Miner Res 1994;9:705-714.
37. Kawamura H, Otsuka T, Tokuda H, et al. Involvement of p42/p44 MAP kinase in endothelin-1-induced interleukin-6 synthesis in osteoblast-like cells. Bone 1999;24:315-320.
38. Ruetten H, Thiemermann C. Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone. J Physiol Pharmacol 1997;48:675-688.
39. Mullol J, Baraniuk JN, Logun C, et al. Endothelin-1 induces GM-CSF, IL-6 and IL-8 but not G-CSF release from a human bronchial epithelial cell line (BEAS-213). Neuropeptides 1996;30:551-556.
40. Stankova J, D'Orleans-Juste P, Rola-Pleszczynski M. ET-1 induces IL-6 gene expression in human umbilical vein endothelial cells: synergistic effect of IL-1. Am J Physiol 1996;271:C1073-C1078.
41. Rae GA, Trybulec M, de Nucci G, et al. Endothelin-1 releases eicosanoids from rabbit isolated perfused kidney and spleen. J Cardiovasc Pharmacol 1989;13:S89-S92; discussion S102.
42. Gutierrez S, Palacios I, Egido J, et al. Endothelin-1 induces loss of proteoglycans; and enhances fibronectin and collagen production in cultured rabbit synovial cells. Eur J Pharmacol 1996;302:191-197.
43. Ramaswamy CM, Eades SC, Venugopal CS, et al. Plasma concentrations of endothelin-like immunoreactivity in healthy horses and horses with naturally acquired gastrointestinal tract disorders. Am J Vet Res 2002;63:454-458.
44. McIlwraith CW. Diseases of joints, tendons, ligaments, and related structures. In: Stashak TS, ed. Adams' lameness in horses. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2002;483-484.
45. Nahir AM, Hoffman A, Lorber M, et al. Presence of immunoreactive endothelin in synovial fluid: analysis of 22 cases. J Rheumatol 1991;18:678-680.
46. Wagner OF, Christ G, Wojta J, et al. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267:16066-16068.
47. Schwarting A, Schlaak J, Lotz J, et al. Endothelin-1 modulates the expression of adhesion molecules on fibroblast-like synovial cells (FLS). Scand J Rheumatol 1996;25:246-256.
48. Messai H, Panasyuk A, Khatib A, et al. Endothelin-1 receptors on cultured rat articular chondrocytes: regulation by age, growth factors, and cytokines, and effect on cAMP production. Mech Ageing Dev 2001;122:519-531.
49. Charles IG, Palmer RM, Hickery MS, et al. Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci U S A 1993;90:11419-11423.
50. Frean SP, Bryant CE, Froling IL, et al. Nitric oxide production by equine articular cells in vitro. Equine Vet J 1997;29:98-102.
51. Simmons EJ, Bertone AL, Hardy J, et al. Nitric oxide synthase activity in healthy and interleukin 1beta-exposed equine synovial membrane. Am J Vet Res 1999;60:714-716.
52. Spreng D, Sigrist N, Jungi T, et al. Nitric oxide metabolite production in the cranial cruciate ligament, synovial membrane, and articular cartilage of dogs with cranial cruciate ligament rupture. Am J Vet Res 2000;61:530-536.
53. del Pozo V, de Arruda-Chaves E, de Andres B, et al. Eosinophiols transcribe and translate messenger RNA for inducible nitric oxide synthase. J Immunol 1997;158:859-864.
54. Bueno AC, Seahorn TL, Comick-Seahorn J, et al. Plasma and urine nitric oxide concentrations in horses given below a low dose of endotoxin. Am J Vet Res 1999;60:969-976.